Morphine Binds Creatine Kinase B and Inhibits Its Activity

Morphine is an analgesic alkaloid used to relieve severe pain, and irreversible binding of morphine to specific unknown proteins has been previously observed. In the brain, changes in the expression of energy metabolism enzymes contribute to behavioral abnormalities during chronic morphine treatment...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in cellular neuroscience Vol. 12; p. 464
Main Authors Weinsanto, Ivan, Mouheiche, Jinane, Laux-Biehlmann, Alexis, Delalande, François, Marquette, Arnaud, Chavant, Virginie, Gabel, Florian, Cianferani, Sarah, Charlet, Alexandre, Parat, Marie-Odile, Goumon, Yannick
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Research Foundation 03.12.2018
Frontiers
Frontiers Media S.A
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Morphine is an analgesic alkaloid used to relieve severe pain, and irreversible binding of morphine to specific unknown proteins has been previously observed. In the brain, changes in the expression of energy metabolism enzymes contribute to behavioral abnormalities during chronic morphine treatment. Creatine kinase B (CK-B) is a key enzyme involved in brain energy metabolism. CK-B also corresponds to the imidazoline-binding protein I which binds dopamine (a precursor of morphine biosynthesis) irreversibly. Using biochemical approaches, we show that recombinant mouse CK-B possesses a μM affinity for morphine and binds to morphine . The complex formed by CK-B and morphine is resistant to detergents, reducing agents, heat treatment and SDS-polyacrylamide gel electrophoresis (SDS-PAGE). CK-B-derived peptides CK-B and CK-B were identified as two specific morphine binding-peptides. , morphine (1-100 μM) significantly reduces recombinant CK-B enzymatic activity. Accordingly, morphine administration (7.5 mg/kg, i.p.) to mice significantly decreased brain extract CK-B activity compared to saline-treated animals. Together, these results show that morphine strongly binds CK-B and inhibits its activity and .
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMCID: PMC6286964
Reviewed by: Jolanta B. Zawilska, Medical University of Lodz, Poland; Jean Albert Boutin, Servier, France
Present Address: Alexis Laux-Biehlmann, Bayer AG, Research & Development, Pharmaceuticals, Berlin, Germany
These authors have contributed equally to this work
Edited by: Lisa Mapelli, University of Pavia, Italy
ISSN:1662-5102
1662-5102
DOI:10.3389/fncel.2018.00464